bioAffinity Technologies to raise about $4 million in registered direct
bioAffinity Technologies, Inc. said it has agreed with an institutional investor to sell common stock in a registered direct financing and a concurrent at-the-market private placement under Nasdaq rules.
Story updates
04:07:39 PM UTC
SquawkNews
bioAffinity Technologies entered a deal with an institutional investor to raise approximately $4M via common stock (or pre-funded warrants) and concurrent private placement warrants at $6.122. Closing is expected on or about Oct. 9, 2026, subject to customary conditions.Material DetailsContext by A…